Panel Discussion: Building a Better Dynamic Between Biopharma & Diagnostics Developer to Deliver Drugs to Patients Faster
Time: 12:30 pm
day: Conference Day One - Track 2
Details:
- How are regulations impacting CDx and assay manufacturers? How are they impacting biopharma?
- What are the performance limitations of current instruments and assays used/needed routinely by biopharma?
- What are the cultural differences between biopharma and diagnostics developers? How do you manage this from a biopharma perspective?
- In what ways can we be improving co-development relationship?
